{"id":21364,"date":"2025-07-10T11:15:11","date_gmt":"2025-07-10T10:15:11","guid":{"rendered":"https:\/\/targetmalaria.org\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/"},"modified":"2025-07-10T11:20:45","modified_gmt":"2025-07-10T10:20:45","slug":"new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants","status":"publish","type":"post","link":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/","title":{"rendered":"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0"},"content":{"rendered":"
Post\u00e9 le 10 juillet 2025<\/div>
\"Photo<\/figure>
Par Ndeye Mane Sall<\/h6>

Charg\u00e9e de la communication mondiale, Imperial College London
Target Malaria UK<\/p><\/div><\/div>\n\n\n

\n
\n

Cette semaine, Medecines for Malaria Venture (MMV) et l\u2019entreprise pharmaceutique Novartis ont annonc\u00e9<\/a> une nouvelle avanc\u00e9e dans la lutte contre le paludisme.\u00a0<\/h3>\n\n\n\n

Novartis<\/a> a obtenu l’autorisation de mise sur le march\u00e9 du premier m\u00e9dicament contre le paludisme destin\u00e9 aux nouveau-n\u00e9s et aux nourrissons. La d\u00e9cision positive de Swissmedic<\/a>, prise dans le cadre d’une initiative mondiale sp\u00e9ciale en mati\u00e8re de sant\u00e9, devrait d\u00e9sormais conduire \u00e0 une autorisation rapide dans huit pays africains.  <\/p>\n\n\n\n

Il s’agit d’une avanc\u00e9e consid\u00e9rable dans la lutte contre le paludisme. Avant cette approbation, il n’existait aucun traitement approuv\u00e9 contre le paludisme pour les nourrissons pesant moins de 4,5 kg, ce qui constituait une lacune th\u00e9rapeutique. Ils \u00e9taient trait\u00e9s \u00e0 l’aide de formulations destin\u00e9es aux enfants plus \u00e2g\u00e9s, ce qui pouvait augmenter le risque de surdosage et de toxicit\u00e9. Les vaccins contre le paludisme ne sont pas non plus approuv\u00e9s pour les nourrissons les plus jeunes. <\/p>\n\n\n\n

 Chaque ann\u00e9e, 30 millions de b\u00e9b\u00e9s naissent dans des zones \u00e0 risque en Afrique<\/a>, et une grande enqu\u00eate<\/a> men\u00e9e en Afrique de l’Ouest fait \u00e9tat d’un taux d’infection compris entre 3,4 % et 18,4 % chez les nourrissons de moins de 6 mois.  <\/p>\n\n\n\n

\u00ab Le paludisme est l’une des maladies les plus mortelles au monde, en particulier chez les enfants. Mais avec les ressources et les efforts n\u00e9cessaires, elle peut \u00eatre \u00e9limin\u00e9e \u00bb<\/p>Martin Fitchet, PDG de MMV<\/a><\/cite><\/blockquote><\/figure>\n\n\n\n

Chez Target Malaria, nous saluons cette excellente nouvelle pour les familles et esp\u00e9rons que les investissements dans la recherche sur le paludisme se poursuivront afin de trouver de nouveaux angles d’attaque pour lutter contre cette maladie, en particulier dans les zones qui ont \u00e9t\u00e9 n\u00e9glig\u00e9es, comme les femmes enceintes et les nourrissons.  <\/p>\n\n\n\n

Notre vision est de vivre un jour dans un monde exempt de paludisme, et gr\u00e2ce \u00e0 la cr\u00e9ation de nouveaux outils pour lutter contre cette maladie, cette vision est \u00e0 notre port\u00e9e. <\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Cette semaine, Medecines for Malaria Venture (MMV) et l\u2019entreprise pharmaceutique Novartis ont annonc\u00e9 une nouvelle avanc\u00e9e dans la lutte contre le paludisme.\u00a0 Novartis a obtenu l’autorisation de mise sur le march\u00e9 du premier m\u00e9dicament contre le paludisme destin\u00e9 aux nouveau-n\u00e9s et aux nourrissons. La d\u00e9cision positive de Swissmedic, prise dans le cadre d’une initiative mondiale […]<\/p>\n","protected":false},"author":31,"featured_media":20043,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","featured_image_focal_point":[],"_image_focal_point":[],"footnotes":""},"categories":[88],"profile_tax":[],"class_list":["post-21364","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actus","country-royaume-uni","post_writers-ndeye-mane-sall-fr"],"acf":[],"yoast_head":"\nNouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0 - Target Malaria<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0 - Target Malaria\" \/>\n<meta property=\"og:description\" content=\"Cette semaine, Medecines for Malaria Venture (MMV) et l\u2019entreprise pharmaceutique Novartis ont annonc\u00e9 une nouvelle avanc\u00e9e dans la lutte contre le paludisme.\u00a0 Novartis a obtenu l’autorisation de mise sur le march\u00e9 du premier m\u00e9dicament contre le paludisme destin\u00e9 aux nouveau-n\u00e9s et aux nourrissons. La d\u00e9cision positive de Swissmedic, prise dans le cadre d’une initiative mondiale […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/\" \/>\n<meta property=\"og:site_name\" content=\"Target Malaria\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TargetMalariaGlobal\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-10T10:15:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-10T10:20:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/targetmalaria.org\/wp-content\/uploads\/2025\/03\/iStock-182505788.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorraine Gibson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TargetMalaria\" \/>\n<meta name=\"twitter:site\" content=\"@TargetMalaria\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorraine Gibson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/\"},\"author\":{\"name\":\"Lorraine Gibson\",\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/#\\\/schema\\\/person\\\/492d9f8e39a2bb31b5ac1b64b7581bb0\"},\"headline\":\"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0\",\"datePublished\":\"2025-07-10T10:15:11+00:00\",\"dateModified\":\"2025-07-10T10:20:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/\"},\"wordCount\":356,\"publisher\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/targetmalaria.org\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/iStock-182505788.jpg\",\"articleSection\":[\"Actus\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/\",\"url\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/\",\"name\":\"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0 - Target Malaria\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/targetmalaria.org\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/iStock-182505788.jpg\",\"datePublished\":\"2025-07-10T10:15:11+00:00\",\"dateModified\":\"2025-07-10T10:20:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/#primaryimage\",\"url\":\"https:\\\/\\\/targetmalaria.org\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/iStock-182505788.jpg\",\"contentUrl\":\"https:\\\/\\\/targetmalaria.org\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/iStock-182505788.jpg\",\"width\":800,\"height\":533,\"caption\":\"Pregnant lady with cloth around belly\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/latest\\\/actus\\\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/\",\"name\":\"Target Malaria\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/#organization\",\"name\":\"Target Malaria\",\"url\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/targetmalaria.org\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/target_malaria_bf_logo.png\",\"contentUrl\":\"https:\\\/\\\/targetmalaria.org\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/target_malaria_bf_logo.png\",\"width\":1920,\"height\":1080,\"caption\":\"Target Malaria\"},\"image\":{\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/TargetMalariaGlobal\\\/\",\"https:\\\/\\\/x.com\\\/TargetMalaria\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/target-malaria\",\"https:\\\/\\\/youtube.com\\\/@TargetMalaria\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/targetmalaria.org\\\/fr\\\/#\\\/schema\\\/person\\\/492d9f8e39a2bb31b5ac1b64b7581bb0\",\"name\":\"Lorraine Gibson\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0 - Target Malaria","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/","og_locale":"fr_FR","og_type":"article","og_title":"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0 - Target Malaria","og_description":"Cette semaine, Medecines for Malaria Venture (MMV) et l\u2019entreprise pharmaceutique Novartis ont annonc\u00e9 une nouvelle avanc\u00e9e dans la lutte contre le paludisme.\u00a0 Novartis a obtenu l’autorisation de mise sur le march\u00e9 du premier m\u00e9dicament contre le paludisme destin\u00e9 aux nouveau-n\u00e9s et aux nourrissons. La d\u00e9cision positive de Swissmedic, prise dans le cadre d’une initiative mondiale […]","og_url":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/","og_site_name":"Target Malaria","article_publisher":"https:\/\/www.facebook.com\/TargetMalariaGlobal\/","article_published_time":"2025-07-10T10:15:11+00:00","article_modified_time":"2025-07-10T10:20:45+00:00","og_image":[{"width":800,"height":533,"url":"https:\/\/targetmalaria.org\/wp-content\/uploads\/2025\/03\/iStock-182505788.jpg","type":"image\/jpeg"}],"author":"Lorraine Gibson","twitter_card":"summary_large_image","twitter_creator":"@TargetMalaria","twitter_site":"@TargetMalaria","twitter_misc":{"\u00c9crit par":"Lorraine Gibson","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/#article","isPartOf":{"@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/"},"author":{"name":"Lorraine Gibson","@id":"https:\/\/targetmalaria.org\/fr\/#\/schema\/person\/492d9f8e39a2bb31b5ac1b64b7581bb0"},"headline":"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0","datePublished":"2025-07-10T10:15:11+00:00","dateModified":"2025-07-10T10:20:45+00:00","mainEntityOfPage":{"@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/"},"wordCount":356,"publisher":{"@id":"https:\/\/targetmalaria.org\/fr\/#organization"},"image":{"@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/#primaryimage"},"thumbnailUrl":"https:\/\/targetmalaria.org\/wp-content\/uploads\/2025\/03\/iStock-182505788.jpg","articleSection":["Actus"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/","url":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/","name":"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0 - Target Malaria","isPartOf":{"@id":"https:\/\/targetmalaria.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/#primaryimage"},"image":{"@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/#primaryimage"},"thumbnailUrl":"https:\/\/targetmalaria.org\/wp-content\/uploads\/2025\/03\/iStock-182505788.jpg","datePublished":"2025-07-10T10:15:11+00:00","dateModified":"2025-07-10T10:20:45+00:00","breadcrumb":{"@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/#primaryimage","url":"https:\/\/targetmalaria.org\/wp-content\/uploads\/2025\/03\/iStock-182505788.jpg","contentUrl":"https:\/\/targetmalaria.org\/wp-content\/uploads\/2025\/03\/iStock-182505788.jpg","width":800,"height":533,"caption":"Pregnant lady with cloth around belly"},{"@type":"BreadcrumbList","@id":"https:\/\/targetmalaria.org\/fr\/latest\/actus\/new-breakthrough-in-malaria-treatment-for-newborn-babies-and-young-infants\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/targetmalaria.org\/fr\/"},{"@type":"ListItem","position":2,"name":"Nouvelle avanc\u00e9e dans les traitements contre le paludisme chez les nouveau-n\u00e9s et les nourrissons \u00a0"}]},{"@type":"WebSite","@id":"https:\/\/targetmalaria.org\/fr\/#website","url":"https:\/\/targetmalaria.org\/fr\/","name":"Target Malaria","description":"","publisher":{"@id":"https:\/\/targetmalaria.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/targetmalaria.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/targetmalaria.org\/fr\/#organization","name":"Target Malaria","url":"https:\/\/targetmalaria.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/targetmalaria.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/targetmalaria.org\/wp-content\/uploads\/2025\/08\/target_malaria_bf_logo.png","contentUrl":"https:\/\/targetmalaria.org\/wp-content\/uploads\/2025\/08\/target_malaria_bf_logo.png","width":1920,"height":1080,"caption":"Target Malaria"},"image":{"@id":"https:\/\/targetmalaria.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/TargetMalariaGlobal\/","https:\/\/x.com\/TargetMalaria","https:\/\/www.linkedin.com\/company\/target-malaria","https:\/\/youtube.com\/@TargetMalaria"]},{"@type":"Person","@id":"https:\/\/targetmalaria.org\/fr\/#\/schema\/person\/492d9f8e39a2bb31b5ac1b64b7581bb0","name":"Lorraine Gibson"}]}},"_links":{"self":[{"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/posts\/21364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/comments?post=21364"}],"version-history":[{"count":2,"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/posts\/21364\/revisions"}],"predecessor-version":[{"id":21367,"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/posts\/21364\/revisions\/21367"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/media\/20043"}],"wp:attachment":[{"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/media?parent=21364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/categories?post=21364"},{"taxonomy":"profile_tax","embeddable":true,"href":"https:\/\/targetmalaria.org\/fr\/wp-json\/wp\/v2\/profile_tax?post=21364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}